With full genetic control and visibility into neural activity and behavior, MIT scientists map out chemical’s role in behavior.

While the brain acquires resistance to continuous treatment with mGluR5 inhibitor drugs, lasting effects may still arise if dosing occurs intermittently and during a developmental-critical period.

Novel method, developed by McGovern Institute researchers, may lead to safer, more efficient gene therapies.

Combat veteran and PhD candidate Omar Rutledge drives research on post-traumatic stress disorder.

Gifts to MIT and Harvard Medical School totaling $9 million will fund independent research on cannabinoid’s influence on brain health and behavior.